in

Forest Laboratories Inc.: PharmaVitae Profile now available at ReportsandReports

Dallas, TX: ReportsandReports announce Forest Laboratories Inc.: PharmaVitae Profile Market Research Report in its Store.
Browse complete Report at: http://www.reportsandreports.com/reports/16328-forest-laboratories-inc-pharmavitae-profile.html
This analysis examines the historical and forecast performance for Forest in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
• Benchmark Forest’s performance against key rivals in the prescription pharmaceutical sector
• See how Lexapro’s patent expiry will undermine Forest’s top-line sales performance
• Evaluate the prospects of the company’s pipeline to fill the gap left by the genericization of Lexapro
• Table Of Contents
• ABOUT DATAMONITOR HEALTHCARE
• About the PharmaVitae team
• Chapter 1 About this profile
• PharmaVitae Explorer database
• Chapter structure
• Executive summary
Quarterly update
Company introduction
Company sales
Company financials
Key products and competitors
Data sourcing
Sales data
Analyst consensus
• Chapter 2 Executive summary
• Key findings
Prescription pharmaceutical sales and growth rate performance, 2002-14
Financial performance, 2002-14
COMPANY: PharmaVitae forecasts at a glance
Strategic insight
SWOT analysis
Strengths
Strong sales and high forecast operating profits to 2011
Weaknesses
Exposure to generic competition, significantly hampering growth prospects
Opportunities
Use search & development business model to bolster pipeline and offset declines from currently marketed portfolio
Threats
Failure of pipeline products to reach the market
Table of Contents
Table of figures
• Chapter 3 Quarterly update
• Latest quarterly sales
Latest prescription pharma product news
Q1 2010
Q4 2009
Q3 2009
Q2 2009
Q1 2009
Latest corporate news
Q1 2010
Q4 2009
Q3 2009
Q2 2009
Q1 2009
Future product milestones
• Chapter 4 Company introduction
• Key findings
Background
Key corporate developments
M&A history
Current corporate structure
Forest Pharmaceuticals
Inwood Laboratories
• Chapter 5 Company sales
• Key findings
Prescription pharmaceutical sales and growth rate analysis, 2002-14
Product analysis
Product analysis, 2002-08
Product analysis, 2008-14
Therapy area analysis
Geographic analysis
Launch/core/expiry analysis
Explanation of launch/core/expiry analysis
Launch analysis, 2008-14
Core analysis, 2008-14
Expiry analysis, 2008-14
Generics analysis, 2008-14
Launch/core/expiry configuration, 2008-14
Molecule type analysis
Externalization analysis
• Chapter 6 Company financials
• Key findings
Reconciliation between PharmaVitae-formatted prescription pharma sales and company-reported total sales, 2002-08
Operating costs and profit analysis
Operating costs and profit analysis, 2002-08
Operating cost ratio and profit margin analysis, 2002-08
Operating cost ratio and profit margin analysis, 2008-14
Operating costs and profit analysis, 2008-14
• Chapter 7 Key products and competitors
• Overview
CNS
Lexapro
Overview
Sales forecast
Namenda
Overview
Sales forecast
Savella
Overview
Sales forecast
• Chapter 8 Appendix
• References
Abbreviations
Exchange rates
About Datamonitor
About Datamonitor Healthcare
Datamonitor consulting
Disclaimer
• List of Tables
• Table 1: Forest – PharmaVitae forecasts at a glance
Table 2: Forest quarterly sales ($m), Q308-Q309
Table 3: Forest future product milestones, 2010-12
Table 4: Forest product portfolio overview ($m), 2002-08
Table 5: Forest product portfolio overview ($m), 2008-14
Table 6: Forest prescription pharmaceutical sales by therapy area ($m), 2008-14
Table 7: Forest prescription pharmaceutical sales by geographic region ($m), 2008-14
Table 8: Forest launch portfolio overview ($m), 2008-14
Table 9: Forest core portfolio overview ($m), 2008-14
Table 10: Forest expiry portfolio overview ($m), 2008-14
Table 11: Forest generics portfolio overview ($m), 2008-14
Table 12: Forest prescription pharmaceutical sales by molecule type ($m), 2008-14
Table 13: Forest prescription pharmaceutical sales by source ($m), 2008-14
Table 14: Total Forest sales by business unit ($m), 2002-08
Table 15: Forest operating revenue/cost analysis ($m), 2002-08
Table 16: Forest operating cost ratio analysis (% of total revenues), 2002-08
Table 17: Forest operating cost ratio analysis (% of total revenues), 2008-14
Table 18: Forest operating revenue/cost analysis ($m), 2008-14
Table 19: Key products overview
Table 20: Lexapro: overview
Table 21: Lexapro: sales forecast ($m), 2008-14
Table 22: Namenda: overview
Table 23: Namenda: sales forecast ($m), 2008-14
Table 24: Savella: overview
Table 25: Savella: sales forecast ($m), 2008-14
Table 26: Exchange rates, 2009

ABBREVIATIONS

Browse all : Healthcare Market Research Reports
http://www.reportsandreports.com/cat/healthcare-market-research.html

Browse all : Datamonitor Market Research Reports
http://www.reportsandreports.com/Publisher/datamonitor-market-research.html-market-research.html

Browse all Newly Published Market Research Reports
http://www.reportsandreports.com/LatestReport.aspx

Original Source : PharmaVitae Market
http://www.reportsandreports.com/reports/7951-astrazeneca-plc-pharmavitae-profile.html
Buy Now : Market Research Report
http://www.reportsandreports.com/

Related Reports:
Forest Laboratories Inc-Deals & Alliances Report
http://www.reportsandreports.com/reports/31326-forest-laboratories-inc-deals-alliances-report.html
Forest Laboratories Inc-Detailed Product Pipeline
http://www.reportsandreports.com/reports/3832-forest-laboratories-inc-detailed-product-pipeline.html
Forest Laboratories Inc.-Deals & Alliances Report
http://www.reportsandreports.com/reports/4275-forest-laboratories-inc-deals-alliances-report.html
Forest Laboratories Inc-Therapeutic Competitors
http://www.reportsandreports.com/reports/3398-forest-laboratories-inc-therapeutic-competitors.html
Forest Laboratories, Inc.
http://www.reportsandreports.com/reports/19766-forest-laboratories-inc.html

About Us:
Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.reportsandreports.com/
Blog: http://reportsnreports.wordpress.com/
Blog: http://reportsandreports.blogspot.com/

AstraZeneca plc: PharmaVitae Profile now available at ReportsandReports

Merging Multiple PDF Files into One